As of 2023, Measles-Containing-Vaccine Second-Dose (MCV2) immunization coverage in Canada stands at 87% among children of the nationally recommended age. The forecast through 2028 shows an increase to 88% in 2024 and stabilizes at 89% from 2025 onwards. This indicates a steady, yet modest improvement in coverage, with a year-on-year increase of approximately 1.15% from 2023 to 2024. The compound annual growth rate (CAGR) for the period from 2024 to 2028 suggests a stable growth trend.
Future trends to watch for include developments in public health initiatives that may enhance vaccination outreach, the influence of public perception on vaccine uptake, and potential impacts of new health policies. Monitoring these factors could provide insights into sustaining or further increasing coverage rates.
